Cisplatin nephrotoxicity and protection by milk thistle extract in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2, Issue 3, 2005, Pages 383-386

  Karimi, Gholamreza ^a   Ramezani, Mohammad ^a   Tahoonian, Zahra ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cisplatin; Milk thistle; Renal toxicity; Silymarin

Indexed keywords

CISPLATIN; CREATININE; METHANOL; NITROGEN; SILYBUM MARIANUM EXTRACT; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; KIDNEY INJURY; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; RENAL PROTECTION; SILYBUM MARIANUM; SPECIES COMPARISON; UREA NITROGEN BLOOD LEVEL;

EID: 24344479620     PISSN: 1741427X     EISSN: None     Source Type: Journal    
DOI: 10.1093/ecam/neh103     Document Type: Article

References (23)

1. Rozeneweing M, Van Hoff D, Slavil M, Maggia FM. cis- Diaminedichloroplatinum, a new anticancer agent. Ann Int Med 1977;86:803-9.
2. Winston JA, Safirstein R. Reduced renal flow in early cisplatin-induced acute renal failure in the rat. Am Physiol 1985;249:F490-6.
3. Greggi Antunes LM, Darin JD, Bianchi M. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats. Pharmacol Res 2000;41:405-11.
4. Chirino YI, Hernandez-pando R, Pedraza-Chaveri J. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 2004;4:20-9.
5. Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 1987;43:247-52.
6. Mora L, Antunes LM, Francescato HD, Bianchi M. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2003;47:517-22.
7. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health 2003;66:469-79.
8. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-8.
9. Mora A, Paya M, Rios J, Alcaraz M. Structure activity relationships of polymetoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidation. Biochem Pharmacol 1990;40:793-4.
10. Singh D, Chander V, Chopra K. Protective effect of catechin on ischemia-reperfusion-induced renal injury in rats. Pharmacol Rep 2005;57:70-6.
11. Zhao B. Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 2005;31:283-94.
12. DerMarderosian A. The Review of Natural Product. St Louis: Fact and Comparison, 2001, 405-9.
13. Fleming T. PDR for Herbal Medicines. New Jersy: Medical Economics Company, 2000, 516-8.
14. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394-401.
15. McClatchey KD. Clinical Laboratory Medicine. London: Williams & Wilkins, 1994, 376-8.
16. Hammersen F. Histology. Munich: Urban and Schwarzenberg, 1985, 1-4.
17. Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant 1996;11:55-62.
18. Heidman HT, Gerkens IF, Jackson EK, Branch RA. Attenuation of cisplatin induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide. Arch Pharmacol 1985;329:201-5.
19. Montine TJ, Borch RF. Role of endogenous sulfur containing nucleophiles in an in vitro model of cis-diamminedichloroplatinium-induced nephrotoxicity. Biochem Pharmacol 1990;39:1751-7.
20. Rao M, Rao MM. Protective effects of selenomethionine against cisplatin-induced renal toxicity in mice and rats. J Pharm Pharmacol 1992;50:687-91.
21. Jones TW, Chopra S, Kaufman JS, Flamenbaum W, Trump B. Cis-diammine-dichloroplatinium-induced acute renal failure in the rat. Lab Invest 1985;52:363-74.
22. Rubanyi GM, Vanhoutte PM. Superoxide anions and hypoxia inactivate endothelium derived relaxing factor. Am J Physiol 1986;250:H822-7.
23. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004;24:354-65.